Skip to Content

187 (Carbidopa and Levodopa (Orally Disintegrating) 25 mg / 100 mg)

Pill with imprint 187 is Yellow, Round and has been identified as Carbidopa and Levodopa (Orally Disintegrating) 25 mg / 100 mg. It is supplied by Sun Pharmaceuticals.

Carbidopa/levodopa is used in the treatment of parkinson's disease; restless legs syndrome; neuroleptic malignant syndrome; gtp-ch deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/levodopa 25 mg / 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 187

Carbidopa and levodopa (orally disintegrating) 25 mg / 100 mg 187

Carbidopa and Levodopa (Orally Disintegrating)

Imprint:
187
Strength:
25 mg / 100 mg
Color:
Yellow
Shape:
Round
Availability:
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Sun Pharmaceuticals
Inactive Ingredients:
povidone
mannitol
calcium silicate
crospovidone
magnesium silicate
magnesium stearate
aspartame
silicon dioxide colloidal
microcrystalline cellulose
D&C Yellow No. 10
FD&C Yellow No. 6
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
47335-0187 Sun Pharmaceutical Industries Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide